OPKO Health
OPK
#5857
Rank
โ‚ฌ0.91 B
Marketcap
1,15ย โ‚ฌ
Share price
-0.74%
Change (1 day)
-23.38%
Change (1 year)

Revenue for OPKO Health (OPK)

Revenue in 2025 (TTM): โ‚ฌ0.57 Billion

According to OPKO Health 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.55 Billion. In 2024 the company made a revenue of โ‚ฌ0.68 Billion a decrease over the revenue in the year 2023 that were of โ‚ฌ0.78 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for OPKO Health from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ0.57 B-15.75%
2024 โ‚ฌ0.68 B-12.27%
2023 โ‚ฌ0.78 B-16.56%
2022 โ‚ฌ0.93 B-40.26%
2021 โ‚ฌ1.56 B34.28%
2020 โ‚ฌ1.16 B44.95%
2019 โ‚ฌ0.80 B-6.99%
2018 โ‚ฌ0.86 B3.99%
2017 โ‚ฌ0.83 B-28.33%
2016 โ‚ฌ1.16 B158.25%
2015 โ‚ฌ0.44 B500.24%
2014 โ‚ฌ74.92 M7.19%
2013 โ‚ฌ69.89 M96.54%
2012 โ‚ฌ35.56 M65.07%
2011 โ‚ฌ21.54 M-18.03%
2010 โ‚ฌ26.28 M186.42%
2009 โ‚ฌ9.17 M35.89%
2008 โ‚ฌ6.75 M
2001 โ‚ฌ1.5 M64.38%
2000 โ‚ฌ0.91 M-30.27%
1999 โ‚ฌ1.31 M20.2%
1998 โ‚ฌ1.09 M333.33%
1997 โ‚ฌ0.25 M0%
1996 โ‚ฌ0.25 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ79.14 B 14,251.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚ฌ37.65 B 6,728.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚ฌ12.23 B 2,119.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ14.40 B 2,512.82%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Alnylam Pharmaceuticals
ALNY
โ‚ฌ2.75 B 399.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ41.25 B 7,381.16%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚ฌ11.82 B 2,043.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
โ‚ฌ0.34 B-37.98%๐Ÿ‡บ๐Ÿ‡ธ USA